In pancreatic cancer, elevated expression of Smad7 associates with a better prognosis as compared to patients with lower expression, who show higher incidence of lymph node and liver metastasis after surgery [81]. This evidence concerns the gene SMAD7 and familial pancreatic carcinoma.